Search

中文 / English

Address: No. 35, Simiao Road, Daxing Biomedical Industrial Base, Zhongguancun Science Park, Daxing District, Beijing
 Copyright: Beijing Minhai Biological Technology Co., Ltd.   
Beijing ICP 10007676    Powered by  www.300.cn Beijing    Beijing Public Security No. 110115000037 Internet Drug Information Service Qualification Certificate (Beijing) Non-operating 20150173

Contact

Administrative Office: 010-59613600
Supplier consultation: 010-59613585
Recruitment: 010-59613633
Marketing: 010-59613639
Medical support: 010-59613669

Links:

>
>
>
Minhai Company signed a contract with China Aviation Planning and Design Research Institute

Minhai Company signed a contract with China Aviation Planning and Design Research Institute

Release time:
2019/07/03
Page view

  On June 25, 2019, the signing ceremony of the design contract for the construction project of Minhai Biological New Vaccine International Industrial Base was held in the company's first conference room. The ceremony was presided over by Vice President Xiao Qiyou. The company's chairman Du Weimin, general manager Zheng Haifa, executive deputy general manager Liu Jiankai and other leaders, and deputy general manager Liu Zhongwen of the China Aviation Planning and Design Research Institute, dean Wei Shaohui and dean Zhang Wei of the Institute of Pharmaceutical Engineering Design and Research, attended the meeting.

 

 

  At the ceremony, the company's chairman Du Weimin expressed his expectations for the design of the new vaccine base project, and emphasized the importance of the design work for the construction project. Mr. Du particularly pointed out: We must build excellent projects, pay attention to intelligence, and achieve long-term design concepts and high planning starting points, fully reflecting the requirements of scientific, standardization, intelligence, humanization, and gardening. After the project is completed, it will become a domestic and foreign biomedical research and development institution and a base for international talent research and development; establish the overall image of the biopharmaceutical industry as "international first-class, domestic leader".

 
Liu Zhongwen, deputy general manager of CAAC said: The construction project of Minhai Biological New Vaccine International Industrial Base is a very good project. We will cherish this cooperation opportunity and send the most outstanding designer team according to the most advanced design concept Make this project a good product, and live up to the expectations of President Du and the leaders of Minhai!
 
 
Witnessed by the participants, Chairman Du Weimin and Deputy General Manager Liu Zhongwen of CAAC signed the "Construction Engineering Design Contract" on behalf of both parties.